| 10 min read
The Drugs for Neglected Diseases initiative has a new leader – and he’s on a mission to redefine global health for an egalitarian, postcolonial world
Efforts should be made to diagnose OSD conditions correctly, so that when a new treatment arrives – we are ready to put it to work for our patients
The drug development system is broken; the COVID-19 pandemic is an opportunity to take a bold step towards accessible and affordable therapies
China drafts new gene-editing regulations – but concerns over their enforcement remain.
How will the storm whipped up by He Juinkai’s flagrant disregard for medical ethics affect the wider ambitions of the gene-editing field?
As healthcare systems across the globe feel the strain of an increasing (and aging) population, we need someone – or rather something – to lend a help
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal